Earkart IPO is scheduled to open on September 25, 2025, and close on September 29, 2025, with a fixed price of ₹135 per share and a market lot of 1,000 shares. The IPO size is ₹49.26 crore, comprising a fresh issue and offer for sale, to be listed on BSE and SME by October 3, 2025. Earkart operates in the hearing aid and audiology sector, providing advanced hearing solutions and services across India. The Earkart IPO offers investors an opportunity to participate in a niche healthcare segment with growing demand, backed by experienced management and innovative products.
₹00
₹135
₹
Expert Opinions
Market sentiment for Earkart IPO is optimistic, driven by strong financial growth and expansion in the hearing aid solutions market. The company’s strengths include a 35% revenue increase to ₹43.19 crore in FY 2025 and a robust PAT growth of 125% to ₹6.88 crore, supported by innovative product offerings and extensive distribution channels. Risks involve market competition, regulatory changes, and dependency on technological adoption among end consumers.
Valuation analysis of financial year 2025 for Earkart IPO highlights a Return on Equity (ROE) of 34.55%, ROCE of 47.32%, and a Net Asset Value (NAV) of ₹19.08, reflecting solid profitability and asset strength. Long-term investors may benefit from Earkart’s positioning in a growing healthcare niche, while short-term investors should consider inherent sector volatility.
Investor Considerations
Earkart IPO has demonstrated strong company performance with revenue increasing 36% from ₹31.97 crore in FY 2024 to ₹43.19 crore in FY 2025, accompanied by a PAT margin of 15.93% and improving operational efficiency. The healthcare sector outlook for hearing aids remains favorable due to increasing awareness, aging population, and rising demand for audiology solutions. The Earkart IPO valuation for financial year 2025 shows a Price to Book Value of 7.08, and Debt to Equity of 0.26, signifying healthy profitability and conservative leverage.
Growth prospects include product innovations, expanded market penetration, and enhanced distribution channels. Risks involve regulatory changes, competitive pressures, and technology adoption challenges. This IPO suits long-term investors attracted to healthcare growth, while short-term investors need to consider market volatility and sector responsiveness.
FAQs
Earkart IPO Current GMP is ₹00.
Earkart IPO Expected Returns is 0.00%.
Earkart IPO estimated listing price is ₹135.